Literature DB >> 27920946

Insights in Public Health: Substance Use in Pregnant Women in Hawai'i: Extending Our Capacity and Compassion.

Rebecca Delafield1, Tricia E Wright1.   

Abstract

Substance use can have serious consequences for the health and well-being of individuals. The problem is of particular concern when it involves pregnant women due to health risks for the mother and the fetus. In utero exposure to either legal (eg, alcohol, cigarettes, and certain prescription drugs) or illicit (eg, amphetamines, cocaine, and opioids) substances can result in potentially serious and long-lasting health problems for infants. Available data from Hawai'i indicate that substance use among pregnant women is higher than national targets, which reflect the fact that there is essentially no acceptable rate of use of these substances. Developing an effective system to support virtual elimination of substance use in pregnancy requires broad-based strategies. Progress is being made in Hawai'i to better identify and address substance use in pregnancy. These efforts are being guided by a variety of stakeholders who are dedicated to improving the healthcare and health outcomes for this population. However, significant challenges to the system remain, including provider shortages, lack of local investment, and limited capacity of appropriate, individualized treatment.

Entities:  

Mesh:

Year:  2016        PMID: 27920946      PMCID: PMC5125361     

Source DB:  PubMed          Journal:  Hawaii J Med Public Health        ISSN: 2165-8242


  19 in total

1.  An integrated brief intervention to address smoking in pregnancy.

Authors:  Jacqueline A Bowden; Debra A Oag; Kate L Smith; Caroline L Miller
Journal:  Acta Obstet Gynecol Scand       Date:  2010       Impact factor: 3.636

Review 2.  Contraceptive use and method choice among women with opioid and other substance use disorders: A systematic review.

Authors:  Mishka Terplan; Dennis J Hand; Melissa Hutchinson; Elizabeth Salisbury-Afshar; Sarah H Heil
Journal:  Prev Med       Date:  2015-04-18       Impact factor: 4.018

3.  Committee opinion no. 633: Alcohol abuse and other substance use disorders: ethical issues in obstetric and gynecologic practice.

Authors: 
Journal:  Obstet Gynecol       Date:  2015-06       Impact factor: 7.661

4.  Insights in Public Health: Improving Health for Mothers, Infants, and Families with the Hawai'i Maternal and Infant Health Collaborative.

Authors:  Donald K Hayes; Candice R Calhoun; Lin Joseph; JoAnn Y Farnsworth; Kimberly B Arakaki
Journal:  Hawaii J Med Public Health       Date:  2016-10

Review 5.  Concomitance between childhood sexual and physical abuse and substance use problems. A review.

Authors:  Tracy L Simpson; William R Miller
Journal:  Clin Psychol Rev       Date:  2002-02

6.  Women-Centered Drug Treatment Services and Need in the United States, 2002-2009.

Authors:  Mishka Terplan; Nyaradzo Longinaker; Lindsay Appel
Journal:  Am J Public Health       Date:  2015-09-17       Impact factor: 9.308

7.  Methamphetamines and pregnancy outcomes.

Authors:  Tricia E Wright; Renee Schuetter; Jacqueline Tellei; Lynnae Sauvage
Journal:  J Addict Med       Date:  2015 Mar-Apr       Impact factor: 3.702

8.  ACOG Committee Opinion No. 524: Opioid abuse, dependence, and addiction in pregnancy.

Authors: 
Journal:  Obstet Gynecol       Date:  2012-05       Impact factor: 7.661

Review 9.  Psychologists partnering with obstetricians and gynecologists: Meeting the need for patient-centered models of women's health care delivery.

Authors:  Ellen L Poleshuck; James Woods
Journal:  Am Psychol       Date:  2014 May-Jun

10.  Early start: an integrated model of substance abuse intervention for pregnant women.

Authors:  Cosette Taillac; Nancy Goler; Mary Anne Armstrong; Kathleen Haley; Veronica Osejo
Journal:  Perm J       Date:  2007
View more
  1 in total

1.  Methamphetamine Use in Pregnant Women in Hawai'i: A Case Series.

Authors:  Jennifer M Chin; Marguerite L Bartholomew
Journal:  Hawaii J Health Soc Welf       Date:  2020-05-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.